In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. (Q44285254)
Jump to navigation
Jump to search
scientific article published in January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. |
scientific article published in January 2003 |
Statements
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship (English)
Dirk B Mendel
A Douglas Laird
Xiaohua Xin
Sharianne G Louie
James G Christensen
Guangmin Li
Randall E Schreck
Tinya J Abrams
Theresa J Ngai
Leslie B Lee
Lesley J Murray
Jeremy Carver
Emily Chan
Katherine G Moss
Joshua O Haznedar
Juthamas Sukbuntherng
Robert A Blake
Li Sun
Cho Tang
Todd Miller
Sheri Shirazian
Gerald McMahon
Julie M Cherrington
1 January 2003